PEPTIDEREPORT

Primary regulatory

Targeting Aging with Metformin (TAME): ClinicalTrials.gov

ClinicalTrials.gov registry entry for the TAME (Targeting Aging with Metformin) trial, a multi-center study investigating whether metformin can delay the onset of age-related diseases in non-diabetic adults.

ClinicalTrials.gov / U.S. National Library of MedicinePublished 2015-05-04Accessed 2026-07-01

Open original source

Registry record

Source metadata

Publisher
ClinicalTrials.gov / U.S. National Library of Medicine
Source type
Primary regulatory
Registry ID
clinicaltrials-gov-tame

Source usage

Linked from 4 pages

Compound

Metformin

Evidence curation

Best Compounds for Longevity Research

Guide

Peptide Category Explainers: How Every Compound Class on This Site Is Defined

Guide

Peptide Half-Life Reference Table

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.